Altamira Therapeutics Ltd. business relationships
Companies named in Altamira Therapeutics Ltd.’s 20-F filed 2025-04-30, and public companies whose annual reports name Altamira Therapeutics Ltd.. Each link shows the sentence it came from. Scores are Engagemii’s AI visibility scores.
- AEO visibility
- 4.7 / 10
- AI naming
- 22 / 100 Top 1% in its category
- Agent readiness
- 20 / 100
- AI adoption
- 0 / 100
Layers: Peptides
Named in Altamira Therapeutics Ltd.’s annual report 1
“stake of 49% in Altamira Medica AG or partner our AM-125 development program, or that we will do so in accordance with our expected timeline.” SEC filing
Links are read automatically from SEC annual reports (10-K, 20-F, 40-F). In a hand check of random links, about 8 in 10 were real business relationships, so every link carries its source sentence.